BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionNatixis Advisors, L.p.
Latest Disclosed Ownership13,617 shares
Latest Disclosed Value $ 769
Natixis Advisors, L.p. ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 13, 2026 - Natixis Advisors, L.p. filed a 13F-HR form disclosing ownership of 13,617 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $769,224 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 0 shares of BioMarin Pharmaceutical Inc.. The current value of the position is $744,305 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,617 13,617 1 0.0011
2026-02-10 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -11,018 -100.00 0 0.0000
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,018 -14,212 -56.33 1 -100.00 0.0009
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,230 -7,996 -24.07 1 -50.00 0.0022
2025-05-08 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,226 13,488 68.34 2 100.00 0.0043
2025-02-10 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,738 19,738 1 0.0024
2024-11-06 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -18,901 -100.00 0 -100.00
2024-08-01 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,901 -36,548 -65.91 2 -75.00 0.0034
2024-04-25 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 55,449 -4,170 -6.99 5 -20.00 0.0111
2024-02-06 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 59,619 -248 -0.41 6 0.00 0.0151
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 59,867 116 0.19 5 0.00 0.0162
2023-08-15 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 59,751 -1,207 -1.98 5 0.00 0.0160
2023-05-11 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 60,958 -1,387 -2.22 6 -16.67 0.0204
2023-01-27 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 62,345 -13,239 -17.52 6 -99.91 0.0244
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 75,584 7,171 10.48 6,407 13.02 0.0271
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 68,413 8,047 13.33 5,669 21.81 0.0249
2022-05-12 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 60,366 -4,016 -6.24 4,654 -18.18 0.0177
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 64,382 8,867 15.97 5,688 32.56 0.0217
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 55,515 25,314 83.82 4,291 70.28 0.0176
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,201 10,137 50.52 2,520 66.34 0.0118
2021-05-05 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,064 -34,582 -63.28 1,515 -68.38 0.0079
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 54,646 16,968 45.03 4,792 67.14 0.0276
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 37,678 4,153 12.39 2,867 -30.67 0.0180
2020-08-11 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,525 18,053 116.68 4,135 216.37 0.0274
2020-04-27 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,472 1,814 13.28 1,307 13.16 0.0107
2020-02-10 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,658 -15,841 -53.70 1,155 -54.29 0.0081
2019-08-12 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,499 -3,943 -11.79 2,527 -14.94 0.0206
2019-05-15 2019-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 33,442 434 1.31 2,971 5.73 0.0260
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,442 434 2,971
2019-02-13 2018-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 33,008 -743 -2.20 2,810 -14.15 0.0277
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,008 -743 2,810
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,751 -1,105 -3.17 3,273 -0.30 0.0288
2018-08-14 2018-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 34,856 17,437 100.10 3,283 132.51 0.0314
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,856 3,283
2018-05-10 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,419 -430 -2.41 1,412 -11.31 0.0139
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,849 12 0.07 1,592 -4.10 0.0162
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,837 2,592 17.00 1,660 19.86 0.0175
2017-07-27 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,245 55 0.36 1,385 3.90 0.0150
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,190 2,478 19.49 1,333 26.59 0.0148
2017-02-07 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,712 1,826 16.77 1,053 4.57 0.0127
2016-11-04 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,886 10,886 0.00 1,007 0.0130
2016-02-12 2015-12-31 13F BIOMARIN COM 09061G101 0 0 0 0.0000
2015-11-12 2015-09-30 13F BIOMARIN COM 09061G101 0 0 0 0.0000
2014-11-03 2014-09-30 13F BIOMARIN COM 09061G101 0 -3,508 -100.00 0 -100.00
2014-08-13 2014-06-30 13F BIOMARIN COM 09061G101 3,508 -495 -12.37 218 -20.15 0.0031
2014-05-13 2014-03-31 13F BIOMARIN COM 09061G101 4,003 -5,422 -57.53 273 -58.82 0.0042
2014-02-12 2013-12-31 13F BIOMARIN COM 09061G101 9,425 3,463 58.08 663 54.19 0.0109
2013-10-30 2013-09-30 13F BIOMARIN COM 09061G101 5,962 5,962 430 0.0079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.